Monoclonal Antibodies as Therapeutic Agents for Inflammatory Diseases
Book:
Frontiers in Clinical Drug Research: Anti-Infectives
Page:
1-54
Author(s):
Jéssica Bairos, Emanuel V. Capela*, Ana P.M. Tavares and Mara G. Freire
Anticancer Therapeutic Strategies in Gliomas: Chemotherapy, Immunotherapy, and Molecularly Targeted Therapy in Adults
Book:
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Page:
283-302
Author(s):
Xiaoyan Hu*, Kexun Lian, Mengmeng Wang and Xun Zhang*
Towards Targeted Therapy: Anticancer Agents Targeting Cell Organelle Mitochondria
Book:
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Page:
218-282
Author(s):
Meghana Manjunath and Bibha Choudhary*
MDM2-p53 Antagonists Under Clinical Evaluation: A Promising Cancer Targeted Therapy for Cancer Patients Harbouring Wild-Type TP53
Book:
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Page:
164-217
Author(s):
Maryam Zanjirband*
Breast Cancer Vaccines: Current Status and Future Approach
Book:
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Page:
108-141
Author(s):
Aytül Gül, Sedef Erkunt Alak, Ceren Gül, Tuğba Karakavuk, Hüseyin Can, Muhammet Karakavuk, Ahmet Efe Köseoğlu, Mert Döşkaya, Aysu Değirmenci Döşkaya, Elif Esin Hameş Tuna, Cemal Ün, Adnan Yüksel Gürüz and Levent Yeniay*
Key Data Management Elements in Clinical Trials for Oncological Therapeutics
Book:
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Page:
1-46
Author(s):
Daniel Liu*, Hualong Sun, Yan Bo and Joey Wang
Bioactive Steroids from Marine Organisms
Book:
Frontiers in Natural Product Chemistry
Page:
247-329
Author(s):
Marina P. Savić*, Marija N. Sakač and Jovana J. Ajduković
Subject Index
Book:
Nanotherapeutic Strategies and New Pharmaceuticals (Part 1)
Page:
223-229
Author(s):
Emerging Nanomaterials for Cancer Therapy
Book:
Nanotherapeutic Strategies and New Pharmaceuticals (Part 1)
Page:
104-139
Author(s):
Sibgha Batool, Maryam Bibi, Abid Mehmood Yousaf, Han Gon Choi and Fakhar ud Din*
Nanotherapeutics in Cancer Treatment
Book:
Nanotherapeutic Strategies and New Pharmaceuticals (Part 1)
Page:
85-103
Author(s):
Niyati H. Patel* and Fahad Hassan Shah